News & Updates
Showing Neurology articles
Showing
Show Multimedia Only

Antiseizure drug yields durable seizure frequency reduction, lowers concomitant medication burden
12 Nov 2021
byJairia Dela Cruz
In the treatment of adults with uncontrolled focal seizures, the long-term, open-label use of cenobamate appears to produce high rates of sustained 100-percent and ≥90-percent seizure reduction, with parallel decreases in concomitant antiseizure medication (ASM) doses, according to two separate post hoc analyses of a phase III C021 trial.
12 Nov 2021



